Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Obinutuzumab
Trade Name Gazyva
Synonyms R7159|afutuzumab|GA101|GA-101|RO 5072759
Drug Descriptions

Gazyva (obinutuzumab) is a glycoengineered anti-CD20 antibody that binds to CD20 on B-cells, resulting in increased antibody-dependent cellular cytotoxicity and induction of apoptosis, and potentially leading to decreased growth of B-cell tumors (PMID: 20194898, PMID: 21220500). Gazyva (obinutuzumab) is FDA approved in combination with Ambochlorin (chlorambucil) for chronic lymphocytic leukemia and in combination with Treanda (bendamustine) or chemotherapy for follicular lymphoma (FDA.gov).

DrugClasses CD20 Antibody 10

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Acalabrutinib + Obinutuzumab Acalabrutinib Obinutuzumab 1 2
Acalabrutinib + Obinutuzumab + Venetoclax Acalabrutinib Obinutuzumab Venetoclax 0 3
Aldesleukin + Cyclophosphamide + Fludarabine + FT516 + Obinutuzumab Aldesleukin Cyclophosphamide FT516 Fludarabine Obinutuzumab 0 1
Atezolizumab + Bendamustine + Obinutuzumab Atezolizumab Bendamustine Obinutuzumab 0 1
Atezolizumab + Bevacizumab + Obinutuzumab + RO6874281 Atezolizumab Bevacizumab Obinutuzumab RO6874281 0 1
Atezolizumab + Cyclophosphamide + Doxorubicin + Obinutuzumab + Prednisone + Vincristine Sulfate Atezolizumab Cyclophosphamide Doxorubicin Obinutuzumab Prednisone Vincristine Sulfate 0 1
Atezolizumab + Lenalidomide + Obinutuzumab Atezolizumab Lenalidomide Obinutuzumab 0 1
Atezolizumab + Obinutuzumab Atezolizumab Obinutuzumab 0 2
Atezolizumab + Obinutuzumab + Polatuzumab vedotin-piiq Atezolizumab Obinutuzumab Polatuzumab vedotin-piiq 0 1
Atezolizumab + Obinutuzumab + RO6874281 Atezolizumab Obinutuzumab RO6874281 0 1
Atezolizumab + Obinutuzumab + RO6958688 Atezolizumab Obinutuzumab RO6958688 0 1
Atezolizumab + Obinutuzumab + Venetoclax Atezolizumab Obinutuzumab Venetoclax 0 1
Bendamustine + Obinutuzumab Bendamustine Obinutuzumab 1 2
Bendamustine + Obinutuzumab + Parsaclisib Bendamustine Obinutuzumab Parsaclisib 0 1
Bendamustine + Obinutuzumab + Venetoclax Bendamustine Obinutuzumab Venetoclax 1 3
CC-99282 + Obinutuzumab CC-99282 Obinutuzumab 0 1
Chlorambucil + Obinutuzumab Chlorambucil Obinutuzumab 1 4
Chlorambucil + Obinutuzumab + Umbralisib Chlorambucil Obinutuzumab Umbralisib 0 1
Cyclophosphamide + Doxorubicin + Obinutuzumab + Prednisone + RO7082859 + Vincristine Sulfate Cyclophosphamide Doxorubicin Obinutuzumab Prednisone RO7082859 Vincristine Sulfate 0 1
Cyclophosphamide + Doxorubicin + Obinutuzumab + Prednisone + Vincristine Sulfate Cyclophosphamide Doxorubicin Obinutuzumab Prednisone Vincristine Sulfate 1 2
Cyclophosphamide + Fludarabine + FT596 + Obinutuzumab Cyclophosphamide FT596 Fludarabine Obinutuzumab 0 1
Cyclophosphamide + Fludarabine + Ibrutinib + Obinutuzumab Cyclophosphamide Fludarabine Ibrutinib Obinutuzumab 0 1
Cyclophosphamide + Fludarabine + Obinutuzumab Cyclophosphamide Fludarabine Obinutuzumab 0 0
Duvelisib + Obinutuzumab Duvelisib Obinutuzumab 0 1
Entospletinib + Obinutuzumab Entospletinib Obinutuzumab 0 1
Iberdomide + Obinutuzumab Iberdomide Obinutuzumab 0 1
Ibrutinib + Lenalidomide + Obinutuzumab + Prednisone + Venetoclax Ibrutinib Lenalidomide Obinutuzumab Prednisone Venetoclax 0 1
Ibrutinib + Obinutuzumab Ibrutinib Obinutuzumab 0 8
Ibrutinib + Obinutuzumab + Venetoclax Ibrutinib Obinutuzumab Venetoclax 0 4
Idasanutlin + Obinutuzumab Idasanutlin Obinutuzumab 0 1
Idasanutlin + Obinutuzumab + Rituximab + Venetoclax Idasanutlin Obinutuzumab Rituximab Venetoclax 0 1
Idasanutlin + Obinutuzumab + Venetoclax Idasanutlin Obinutuzumab Venetoclax 0 1
Idelalisib + Obinutuzumab Idelalisib Obinutuzumab 0 1
Lenalidomide + Obinutuzumab Lenalidomide Obinutuzumab 0 2
Lenalidomide + Obinutuzumab + Polatuzumab vedotin-piiq Lenalidomide Obinutuzumab Polatuzumab vedotin-piiq 0 1
Lenalidomide + Obinutuzumab + Venetoclax Lenalidomide Obinutuzumab Venetoclax 0 2
Obinutuzumab Obinutuzumab 0 10
Obinutuzumab + Otlertuzumab Obinutuzumab Otlertuzumab 0 1
Obinutuzumab + Pinatuzumab Vedotin + Rituximab Obinutuzumab Pinatuzumab Vedotin Rituximab 0 1
Obinutuzumab + Polatuzumab vedotin-piiq Obinutuzumab Polatuzumab vedotin-piiq 0 1
Obinutuzumab + Polatuzumab vedotin-piiq + Rituximab Obinutuzumab Polatuzumab vedotin-piiq Rituximab 0 1
Obinutuzumab + Polatuzumab vedotin-piiq + Venetoclax Obinutuzumab Polatuzumab vedotin-piiq Venetoclax 0 1
Obinutuzumab + rhIL-15 Obinutuzumab rhIL-15 0 1
Obinutuzumab + RO7082859 + Tocilizumab Obinutuzumab RO7082859 Tocilizumab 0 1
Obinutuzumab + Umbralisib Obinutuzumab Umbralisib 0 1
Obinutuzumab + Vemurafenib Obinutuzumab Vemurafenib 0 1
Obinutuzumab + Venetoclax Obinutuzumab Venetoclax 1 6
Obinutuzumab + Venetoclax + Zanubrutinib Obinutuzumab Venetoclax Zanubrutinib 0 1
Obinutuzumab + Zanubrutinib Obinutuzumab Zanubrutinib 0 2


Additional content available in CKB BOOST